ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Biocatalyst developer Codexis sold 6 million shares for $13.00 per share in an initial public offering, raising $78 million. The Redwood City, Calif.-based company had $83 million in revenue last year, up 64% from the year before, but it has yet to turn a profit. Codexis’ biggest revenue source is a biofuels development pact with Shell. Separately, the French oil company Total has acquired an interest in Coskata, a Warrenville, Ill., biofuels developer. Existing Coskata investors include General Motors and several private equity firms.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter